홈

Invited Speakers & Chairpersons

검색

Day 1 – June 25 (Thu)

AOCC-IBUS Intestinal Ultrasound Workshop - Advanced (Module 3) June 25 (Thu), 08:30-12:30 | Room C
Chairperson(s)
Speaker(s)
  • IUS 2026: What’s New for IUS in Crohn’s Disease?
     Kayal Vizhi Nagarajan Aster CMI Hospital
    India
  • Interactive Video Presentation 1: IUS in Crohn’s Disease - What’s Your Diagnosis?
     Yoon-kyo An Mater Hospital Brisbane
    Australia
  • IUS 2026: What’s New for IUS in Ulcerative Colitis?
     Alex Hwong-Ruey Leow Pantai Hospital Kuala Lumpur
    Malaysia
  • Interactive Video Presentation 2: IUS in Ulcerative Colitis - What’s Your Diagnosis?
     Joyce Wing Yan Mak The Chinese University of Hong Kong
    Hong Kong, China
  • Interactive Video Case Presentations 3: Scoring Activity and Response in Crohn’s Disease and Ulcerative Colitis
     Kerri Novak University of Calgary
    Canada
  • Interactive Case Presentation 4: Detecting Complications in Crohn’s Disease
     Sung Wook Hwang University of Ulsan
    Korea
  • Interactive Case Presentation 5: TPUS
     Shintaro Sagami Kitasato University
    Japan
  • Interactive Case Presentation 6: Pregnancy, Post op, and beyond IBD
     Ryan Mathias The Queen Elizabeth Hospital
    Australia
  • IUS and Future Development
     Mariangela Allocca University Vita-Salute San Raffaele
    Italy

Day 1 – June 25 (Thu)

RAPID Forum Changing Landscape of Intestinal Diseases in Asia June 25 (Thu), 09:30-11:30 | Room D
Chairperson(s)
Speaker(s)
  • Empowering IBD Care Through Education: Insights from the China Experience
     Yan Chen Zhejiang University
    China
  • From First Symptom to Specialist: Reducing Delays in IBD Diagnosis
     Luan Minh Dang University Medical Center, Ho Chi Minh City University
    Vietnam
  • Implementing Intestinal Ultrasound Service for IBD Patients in Indonesia: Challenges and Opportunities
     Rabbinu Rangga Pribadi University of Indonesia, Cipto Mangunkusumo National Central General Hospital
    Indonesia
  • Management of Rectal Neuroendocrine Tumors in Mongolia
     Bayasgalan Luvsandagva Ulaanbaatar Songdo Hospital
    Mongolia
  • Artificial Intelligence in Colonoscopy: Screening and Surveillance in Asia Perspective
     Satimai Aniwan Chulalongkorn University
    Thailand

Day 1 – June 25 (Thu)

AI Educational Workshop (Kor) Demystifying AI for Gastroenterologists: From Basics to Clinical Research June 25 (Thu), 10:30-12:00 | Room B
Chairperson(s)
Speaker(s)
  • Past, Present and Future Directions in Medical AI
     Jong Chul Ye KAIST
    Korea
  • From Hypothesis to Model: How Clinicians Can Lead AI Study Design
     Sang Hyun Kim The Catholic University of Korea
    Korea
  • From Data to Algorithm: How AI Models Are Developed and Validated
     Jae Gon Lee Hanyang University
    Korea
  • Responsible AI Integration in Clinical Settings: Legal and Ethical Perspectives
     A Reum Choe Ewha Womans University
    Korea

Day 1 – June 25 (Thu)

KASID-MSID Joint Symposium June 25 (Thu), 11:30-12:30 | Room D
Chairperson(s)
Speaker(s)
  • Current Situation with Inflammatory Bowel Disease in Mongolia
    Ariunzul Dashdondog The First Central Hospital of Mongolia
    Mongolia
  • The Changing Epidemiology of IBD in Korea: Past, Present, and Future
     Hongsub Lee Inje University
    Korea

Day 1 – June 25 (Thu)

Luncheon Symposium 1 Deep Healing, Real Results: Redefining Success in Mild-to-Moderate UC June 25 (Thu), 12:30-13:10 | Room B
Chairperson(s)
Speaker(s)
  • From Endoscopic to Histological Healing: Can We Target Deeper with Optimized Mesalamine Therapy?
     Fernando Magro University of Porto
    Portugal
  • The Power of Optimization ? Implementation in Clinical Practice
     Sung Wook Hwang University of Ulsan
    Korea

Day 1 – June 25 (Thu)

AOCC-ECCO Forum State-of-the-Art Perspectives on IBD Management June 25 (Thu), 13:30-15:30 | Room B
Chairperson(s)
Speaker(s)
  • IBD Epidemiology: Evolving Trends and Future Perspectives
     Sung Noh Hong Sungkyunkwan University
    Korea
  • New Horizons in Therapeutic Targeting Beyond Endoscopic Remission
     Marietta Iacucci University College Cork
    Ireland
  • Standard of Care: Practical Barriers and Overcoming Strategies
     Joyce Wing Yan Mak The Chinese University of Hong Kong
    Hong Kong, China
  • Personalized Treatment Strategies toward Precision Medicine
     Joana Torres University of Lisbon
    Portugal

Day 1 – June 25 (Thu)

Basic Forum (KASID-KAI) Beyond Microbiome, Beyond IBD: Expanding the Horizons of Gut Immunology June 25 (Thu), 14:00-15:30 | Room C
Chairperson(s)
Speaker(s)
  • From Microbes to Metabolites: Postbiotic Insights into Gut Immune?Metabolic Cross-Talk
     Munhyung Bae Gachon University
    Korea
  • Multi-Biome Analysis Identifies Distinct Gut Microbial Signatures and Their Crosstalk in IBD
     Shintaro Akiyama University of Tsukuba
    Japan
  • Anti-Commensal IgG as a Pathogenic Driver of Intestinal Inflammation in Inflammatory Bowel Disease
     Kwang Soon Kim POSTECH
    Korea
  • Multi-Omics Analysis for Early Prediction and Mechanistic Insights into GI-GVHD
     Seung Bum Lee University of Ulsan
    Korea

Day 1 – June 25 (Thu)

Clinical Symposium 1 (AI) AI Revolution in IBD Care: From Innovation to a Trusted Partner June 25 (Thu), 15:50-17:20 | Room B
Chairperson(s)
Speaker(s)
  • AI Revolution in Ulcerative Colitis Endoscopy
     Kento Takenaka Institute of Science Tokyo
    Japan
  • Training AI to Detect What Pathologists See: Inflammation in IBD Histology
     Ji Eun Kim Sungkyunkwan University
    Korea
  • The LLM Revolution in IBD
     Chang Seok Bang Hallym University
    Korea
  • Implementing AI in IBD Care: Challenges and Future Perspectives
     Marietta Iacucci University College Cork
    Ireland

Day 1 – June 25 (Thu)

KASID PG Course (Kor) Smarter and Deeper: Core Strategies for Optimized IBD Management June 25 (Thu), 15:50-17:20 | Room C
Chairperson(s)
Speaker(s)
  • Practical Therapeutic Strategies for 5-ASA, Steroids, and Immunomodulators
     Dae Sung Kim Konyang University
    Korea
  • Initiating Advanced Therapy: Choosing the Right Biologic or Small Molecule for the Right Patient
     Kang-Moon Lee The Catholic University of Korea
    Korea
  • Seeing Beyond the Lesion: IBD Dysplasia Management Today
     Eun Ran Kim Sungkyunkwan University
    Korea
  • IBD as a Multisystem Disease: Managing Extraintestinal Manifestations
     Han Hee Lee The Catholic University of Korea
    Korea

Day 1 – June 25 (Thu)

MDT Case Discussion Multidisciplinary Approach in Challenging Cases June 25 (Thu), 15:50-17:20 | Room D
Chairperson(s)
Speaker(s)
  • A 15-Year-Old Man Presented with Abdominal Pain
     Tae Hyeong Kim Kyung Hee University
    Korea
  • Perioperative Managements of Crohn’s Disease in a 24-Year-Old Male Presenting with Fever
     Motoi Uchino Hyogo Medical University
    Japan
  • A 51-Year-Old Man with ASUC and Psoriasis
     Yubei Gu Shanghai Jiao Tong University
    China

Day 2 – June 26 (Fri)

Breakfast with Master 1 Beyond the Clinical Trial Data : Impact of Real-World Experience of ZEPOSIA® June 26 (Fri), 07:30-08:00 | Room B
Chairperson(s)
Speaker(s)
  • Refining Evidence-Based Strategies in UC Practice: Positioning
     Dong Hyun Kim Chonnam National University
    Korea

Day 2 – June 26 (Fri)

Breakfast with Master 2 Sequential Treatment in Ulcerative Colitis June 26 (Fri), 07:30-08:00 | Room C
Chairperson(s)
Speaker(s)
  • The Current Role of Filgotinib in Ulcerative Colitis
     Fumihito Hirai Fukuoka University
    Japan

Day 2 – June 26 (Fri)

Breakfast with Master 3 Start Strong in Ulcerative Colitis with Upadacitinib June 26 (Fri), 07:30-08:00 | Room D
Chairperson(s)
Speaker(s)
  • When Time Matters in Ulcerative Colitis: Upadacitinib for Urgent Disease Control
     Dong Hoon Baek Pusan National University
    Korea
  • Connecting the Dots: Evidence to Insight with Upadacitinib
     Sang-Bum Kang The Catholic University of Korea
    Korea

Day 2 – June 26 (Fri)

Breakfast with Master 4 Transforming Bowel Preparation Strategies in IBD: A Change in Perspective Toward Mini Oral Sulfate Tablets June 26 (Fri), 07:30-08:00 | Room E
Chairperson(s)
Speaker(s)
  • Transforming Bowel Preparation Strategies in IBD: A Change in Perspective Toward Mini Oral Sulfate Tablets
     Jaeseung Soh Hallym University
    Korea

Day 2 – June 26 (Fri)

Breakfast with Master 5 New and Now: Introducing Etrasimod in Ulcerative Colitis June 26 (Fri), 07:30-08:00 | Room F
Chairperson(s)
Speaker(s)
  • Etrasimod in Ulcerative Colitis: Clinical Evidence and Its Role in Therapy
     David T. Rubin University of Chicago
    USA

Day 2 – June 26 (Fri)

Clinical Symposium 2 (ADT) Advanced IBD Therapies: Beyond Competition, Toward Optimization June 26 (Fri), 08:30-10:00 | Room A
Chairperson(s)
Speaker(s)
  • Anti-TNF Therapy: Still Standing Strong and Getting Smarter
     Byong Duk Ye University of Ulsan
    Korea
  • Anti-Integrin Therapy: Ensuring Safety, Enhancing Efficacy
     Vipul Jairath Western University
    Canada
  • IL-23 Inhibitors: Navigating the Expanding Choices in IBD Care
     Silvio Danese University Vita-Salute San Raffaele
    Italy
  • JAK Inhibitors and S1P Receptor Modulators: Emerging Contenders Beyond Biologics
     Taku Kobayashi Kitasato University
    Japan

Day 2 – June 26 (Fri)

Clinical Symposium 3 (Big Data) Transforming IBD Research Through Big Data and Large Cohort Studies June 26 (Fri), 08:30-10:00 | Room B
Chairperson(s)
Speaker(s)
  • Seeing Patterns, Shaping Care: The Evolution of Big Data in IBD Research
     Gilaad G. Kaplan University of Calgary
    Canada
  • Real-World Data in Action: Unlocking Insights from the Korean National Claims Data
     Hyuk Yoon Seoul National University
    Korea
  • Nationwide Big Data Insights into the Epidemiology and Trends of IBD in Taiwan
     Shu-Chen Wei National Taiwan University
    Chinese Taipei
  • Toward Prevention: Expanding Perspectives on Early-Life and Environmental Risk Factors
     Sun-Ho Lee University of Toronto
    Canada

Day 2 – June 26 (Fri)

Translational Symposium (Microbiome/Omics) Microbiome & Omics in IBD: Translating Science into Care June 26 (Fri), 08:30-10:00 | Room C
Chairperson(s)
Speaker(s)
  • Microbial Signatures in IBD: Toward Precision Diagnosis and Subtype Stratification Through Multi-Layer Biomarker Discovery
     Chang Kyun Lee Kyung Hee University
    Korea
  • Shaping the Gut Microbiome: Therapeutic Interventions and Clinical Implications for Inflammatory Bowel Disease
    Hong Koh Yonsei University
    Korea
  • Microbiota-Mediated Intestinal Fibrosis In Crohn’s Disease : From Correlation To Causality
     Ren Mao Sun Yat-sen University
    China
  • Microbes as Targets, Mediators, and Predictors of Therapy Response in IBD
     Eytan Wine The Hospital for Sick Children
    Canada

Day 2 – June 26 (Fri)

Clinical Symposium 4 (Colorectal Neoplasm) Toward Precision Colorectal Cancer Screening: Integrating Risk, Tools, and Innovation June 26 (Fri), 08:30-10:00 | Room D
Chairperson(s)
Speaker(s)
  • FIT or Colonoscopy: What Is the Best Strategy for CRC Screening?
     Wen-Feng Hsu National Taiwan University
    Chinese Taipei
  • Personalized Screening Strategies: Beyond Age-Based CRC Guidelines
     Jae Myung Cha Kyung Hee University
    Korea
  • Revolutionizing Biomarkers in Colorectal Cancer Screening
     Francis K.L. Chan The Chinese University of Hong Kong
    Hong Kong, China
  • Risk-Adapted Surveillance after Polypectomy & ESD: Who, When, and How
     Su Young Kim Yonsei University
    Korea

Day 2 – June 26 (Fri)

AOCC Plenary Session June 26 (Fri), 11:20-12:10 | Room A
Chairperson(s)
Speaker(s)
  • Mesenteric Inflammation-Associated Fibroblasts Drive Intestinal Barrier Dysfunction and Promote Crohn’s Disease Progression
     Jihye Park Ewha Womans University
    Korea
  • Integrated Metabolomic and Genetic Analyses Reveal Loss of Protective Docosahexaenoic Acid as a Key Driver Linking Ultra-Processed Food to Crohn’s Disease Risk
     Jie Chen The Third Xiangya Hospital of Central South University
    China
  • Childhood Exposure to a Sibling with Crohn’s Disease Alters Gut Microbiome and Increases Crohn’s Disease Susceptibility
     Rirong Chen University of Toronto
    Canada
  • Efficacy and Safety of Obefazimod in Moderately to Severely Active Ulcerative Colitis: Pooled Phase 3 Results From ABTECT Trials, Including a Japan and Korea Subgroup Analysis
     Tadakazu Hisamatsu Kyorin University
    Japan

Day 2 – June 26 (Fri)

Luncheon Symposium 2 Beyond Similarity: Clinical and Real-World Insights into Ustekinumab Biosimilars June 26 (Fri), 12:20-13:00 | Room B
Chairperson(s)
Speaker(s)
  • What is Same and Different? : Clinical Value of Ustekinumab Biosimilar
     Eun Soo Kim Kyungpook National University
    Korea
  • From Evidence to Experience: Real-World Application of Ustekinumab Biosimilar in Inflammatory Bowel Disease
     Sang Hyoung Park University of Ulsan
    Korea

Day 2 – June 26 (Fri)

Luncheon Symposium 3 Evolving IBD Care in the Era of IL-23 Inhibitor June 26 (Fri), 12:20-13:00 | Room C
Chairperson(s)
Speaker(s)
  • Unmet Needs in Korean IBD Care: Evolving Expectations for New Therapeutic Options
    Seong-Joon Koh Seoul National University
    Korea
  • Advancing IBD Care with Guselkumab: Insights from Clinical and Real World Evidence
     David T. Rubin University of Chicago
    USA

Day 2 – June 26 (Fri)

Luncheon Symposium 4 Fast-Acting, Long-Lasting Control: Upadacitinib in IBD June 26 (Fri), 13:00-13:40 | Room B
Chairperson(s)
Speaker(s)
  • Optimizing Treatment Strategies in Ulcerative Colitis with Upadacitinib
     Byong Duk Ye University of Ulsan
    Korea
  • Shaping a New Paradigm in Crohn’s Disease Management: The Role of Upadacitinib
     Edward V. Loftus Jr. Mayo Clinic College of Medicine and Science
    USA

Day 2 – June 26 (Fri)

Luncheon Symposium 5 A New Era in IBD Treatment: Optimizing Infliximab Therapy June 26 (Fri), 13:00-13:40 | Room C
Chairperson(s)
Speaker(s)
  • Real-World Experience with Subcutaneous Infliximab: Updated Global Evidence
    Silvio Danese University Vita-Salute San Raffaele
    Italy
  • Personalizing IBD Treatment: The Role of Therapeutic Drug Monitoring in Infliximab Therapy
     Sung Noh Hong Sungkyunkwan University
    Korea

Day 2 – June 26 (Fri)

IMKASID for Young Researchers June 26 (Fri), 14:30-16:00 | Room G
Chairperson(s)
Speaker(s)
  • Optimizing IBD Outcomes Across the Lifespan: Differential Positioning of Biologics and Small Molecules from Pediatrics to Adulthood
     Junghyun Noh Seoul National University
    Korea
  • Clinical Characteristics and Surgical Outcomes of Adolescent-Onset Crohn’s Disease Compared with Pediatric- and Adult-Onset Disease A Nationwide Multicenter Retrospective Cohort Study (CONNECT Study Group)
     Soojin Kang Ewha Womans University
    Korea
  • Clinical Characteristics and Surgical Outcomes of Adolescent-Onset Crohn’s Disease Compared with Pediatric- and Adult-Onset Disease A Nationwide Multicenter Retrospective Cohort Study (CONNECT Study Group)
     Minjee Kim Sungkyunkwan University
    Korea
  • Tailoring Colorectal Cancer Screening for Older Adults: Strategies Beyond Routine Colonoscopy
     Geunhyuk Choi Soonchunhyang University
    Korea
  • New Colorectal Cancer Screening ? Moving Beyond Fit
    Yeojin Lee University of Ulsan
    Korea
  • Artificial Intelligence in Capsule Endoscopy: Current Landscape and Future Perspectives
     Kwangmin Joo Dong-A University
    Korea
  • Gut Microbiome in Inflammatory Bowel Disease: From Dysbiosis to Personalized Therapy
     Hee Won Kwon Kyungpook National University
    Korea

Day 2 – June 26 (Fri)

Meet the Expert 1 Advancing IBD Care with Subcutaneous Infliximab June 26 (Fri), 15:50-16:20 | Exhibition
Speaker(s)
  • Redefining IBD Treatment Strategies: The Role of Subcutaneous Infliximab
     Rupert Leong University of Sydney
    Australia

Day 2 – June 26 (Fri)

Meet the Expert 2 Emerging Treatment in Crohn’s Disease with Fistula June 26 (Fri), 15:50-16:20 | Exhibition
Speaker(s)
  • Clinical Efficacy and Real World Experience with Guselkumab in CD with Fistula
     Vipul Jairath Western University
    Canada

Day 2 – June 26 (Fri)

Clinical Symposium 5 (Pregnancy & Obesity) Global IBD Perspectives: Pregnancy and Obesity across East and West June 26 (Fri), 16:20-17:50 | Room A
Chairperson(s)
Speaker(s)
  • Pregnancy in IBD: Essential Knowledge for Clinicians and Patients
     Joana Torres University of Lisbon
    Portugal
  • IBD and Pregnancy in East Asia: Regional Insights and Clinical Experience
     Eun Mi Song Ewha Womans University
    Korea
  • Epidemiology and Pathophysiology of Obesity and IBD: Asian Perspectives
     Jaeyoung Chun Yonsei University
    Korea
  • Optimizing Medical Therapy in IBD Patients with Obesity
     Siddharth Singh Mayo Clinic Arizona
    USA

Day 2 – June 26 (Fri)

Clinical Symposium 6 (Small Bowel & Nutrition) Current Perspective on Diet and Nutrition in IBD June 26 (Fri), 16:20-17:50 | Room B
Chairperson(s)
Speaker(s)
  • Dietary and Environmental Risk Factors in IBD: Theory and Practice
     Rupa Banerjee AIG Hospitals
    India
  • Impact of Diet and Urban Environment in Crohn’s Disease: Diet-omics Cohort Study
     Rui Feng Sun Yat-Sen University
    China
  • Tools and Challenges of Dietary Assessment in IBD and Colorectal Diseases: Lessons From Clinical Experiences
     Yun Jeong Lim Dongguk university
    Korea
  • Recent Advances in ENTERAL Nutrition for IBD: Beyond THE WALLS
     Robert V Bryant The Queen Elizabeth Hospital
    Australia

Day 2 – June 26 (Fri)

KASID-GEST Joint Symposium Current Status and Future Perspectives in Intestinal Diseases June 26 (Fri), 16:20-17:50 | Room C
Chairperson(s)
Speaker(s)
  • Current Status and Treatment Trends of IBD in Taiwan
     Tzung-Jiun Tsai Kaohsiung Veterans General Hospital
    Chinese Taipei
  • Current Status and Treatment Trends of IBD in Korea
     Joo Hye Song Konkuk University
    Korea
  • Current Status and Treatment Trends of Colorectal Cancer in Taiwan
     Li-Chun Chang National Taiwan University
    Chinese Taipei
  • Current Status and Treatment Trends of Colorectal Neoplasms in Korea
     Seong-Jung Kim Chosun University
    Korea

Day 2 – June 26 (Fri)

Clinical Symposium 7 (AOCC for Pediatricians) Bridging Evidence and Practice in Pediatric IBD June 26 (Fri), 16:20-17:50 | Room D
Chairperson(s)
Speaker(s)
  • Early-Onset Pediatric IBD: From Immune Pathways to Clinical Application
     Takashi Ishige Gunma University
    Japan
  • Pediatric Ulcerative Colitis: Key Updates from the Latest ECCO?ESPGHAN Guidelines
     Eytan Wine The Hospital for Sick Children
    Canada
  • Real-World Practice of Nutritional Therapy in Pediatric Crohn’s Disease
     Hyeji Lim Yonsei University
    Korea
  • Practical Precision Medicine in Pediatric IBD: Advanced Therapies in Real-World Settings
    Mi Jin Kim Sungkyunkwan University
    Korea

Day 3 – June 27 (Sat)

Breakfast with Master 6 A Deep Dive into Shingles Prevention for IBD Patients June 27 (Sat), 07:30-08:00 | Room B
Chairperson(s)
Speaker(s)
  • A Deep Dive into Shingles Prevention for IBD Patients
    Soo Jung Park Yonsei University
    Korea

Day 3 – June 27 (Sat)

Breakfast with Master 7 Advancing the Standard of Care in Ulcerative Colitis: Safety?Driven and Patient?Centered Strategies June 27 (Sat), 07:30-08:00 | Room C
Chairperson(s)
Speaker(s)
  • Optimizing UC Management with Tofacitinib (Xeljanz): Updated Safety Data and Practical Vaccine Checklist for IBD Patients
     Yu Kyung Jun Seoul National University
    Korea

Day 3 – June 27 (Sat)

Breakfast with Master 8 Beyond Similarity: Decision Pathways in IBD Biosimilars June 27 (Sat), 07:30-08:00 | Room D
Chairperson(s)
Speaker(s)
  • The Role of Biosimilars in IBD : Guideline and Decision Insights
     Shin Ju Oh Kyung Hee University
    Korea

Day 3 – June 27 (Sat)

Breakfast with Master 9 Shifting Paradigms in Bowel Preparation: From Volume to Value June 27 (Sat), 07:30-08:00 | Room E
Chairperson(s)
Speaker(s)
  • Differential Clinical Conveniences of OST; Orafang, The First Mover
     Eun Ran Kim Sungkyunkwan University
    Korea

Day 3 – June 27 (Sat)

IBD Guidelines Toward AOCC/KASID IBD Guidelines 2026 June 27 (Sat), 08:30-10:00 | Room A
Chairperson(s)
Speaker(s)
  • AOCC Guidelines for the Diagnosis of IBD
     Jun Shen Shanghai Jiao Tong University
    China
  • AOCC Guidelines for the Treatment of UC
     Dong Hyun Kim Chonnam National University
    Korea
  • AOCC Guideline for the Treatment of Crohn’s Disease
     Shintaro Akiyama University of Tsukuba
    Japan
  • Shaping the Future of the KASID Guidelines
     Won Moon Kosin University
    Korea

Day 3 – June 27 (Sat)

Clinical Symposium 8 (AOCC for Surgeons) All about Surgical Management of IBD June 27 (Sat), 08:30-10:00 | Room B
Chairperson(s)
Speaker(s)
  • Optimal Timing and Perioperative Care for IBD Surgery
     Gyoung Tae Noh Ewha Womans University
    Korea
  • Surgical Techniques and Tips for Bowel Anastomosis in IBD
     Jong Lyul Lee University of Ulsan
    Korea
  • Overcoming Postoperative Complications after IBD Surgery
     Sohyun Kim Yeungnam University
    Korea
  • Surgery for IBD-Associated Cancer/Dysplasia
     Motoi Uchino Hyogo Medical University
    Japan

Day 3 – June 27 (Sat)

Clinical Symposium 9 (Colorectal Neoplasm) Optimizing Treatment Decision Pathways for Early-Stage Colorectal Cancer June 27 (Sat), 08:30-10:00 | Room C
Chairperson(s)
Speaker(s)
  • AI-Assisted Decision-Making in Early-Stage Colorectal Cancer: Current Applications and Future Directions
     Jonathan W. J. Lee National University Hospital
    Singapore
  • Optimizing Endoscopic Treatment for T1 Colorectal Cancer: How Far Can We Go?
     Yunho Jung Soonchunhyang University
    Korea
  • Expanding the Role of Endoscopic Treatment in T2 Colorectal Cancer: Opportunities and Limitations
     Katsuro Ichimasa Showa Medical University
    Japan
  • Selecting Surgery after Non-Curative ESD: Optimal Timing and Criteria
     Dae-hee Pyo The Catholic University of Korea
    Korea

Day 3 – June 27 (Sat)

Clinical Symposium 10 (IBD Masters) Future Directions in IBD: From Global Trends to Personalized Care June 27 (Sat), 10:20-11:50 | Room A
Chairperson(s)
Speaker(s)
  • IBD Goes Global: Western Perspectives on the Rising Burden in Asia
     Gilaad G. Kaplan University of Calgary
    Canada
  • Emerging Therapeutics in IBD: Which Are the Most Promising?
     Jae Hee Cheon Yonsei University
    Korea
  • IBD Tomorrow: From Prediction to Prevention
     David T. Rubin University of Chicago
    USA

Day 3 – June 27 (Sat)

Clinical Symposium 11 (Strictures and Perianal Fistulas in CD) Clinical Challenges in CD: Strictures and Perianal Fistulas June 27 (Sat), 10:20-11:50 | Room B
Chairperson(s)
Speaker(s)
  • Defining and Monitoring Small Bowel Strictures in Crohn’s Disease
     Kerri Novak University of Calgary
    Canada
  • Opening the Way: Advanced Endoscopic Interventions for Crohn’s Strictures
     Hironori Yamamoto Jichi Medical University
    Japan
  • Optimizing Medical Management for Perianal Fistulas
     Siddharth Singh Mayo Clinic Arizona
    USA
  • Surgical Therapies for Complex Perianal Fistula: A Surgeon's Perspective
     Ki-Yun Lim Seoul Songdo Hospital
    Korea

Day 3 – June 27 (Sat)

AOCC for Nurses and Dietitians (Kor) Empowering IBD Care Teams: The Evolving Roles of Nurses and Dietitians June 27 (Sat), 10:20-11:50 | Room C
Chairperson(s)
Speaker(s)
  • Nutritional Management for IBD Patients
     Jihye Park Yonsei University
    Korea
  • Vaccination in IBD: Key Updates for Nursing Practice
     Yehyun Park Ewha Womans University
    Korea
  • IBD Nursing in Education and Psychological Support: Practical Approaches and Lessons from Experience
     Shin Ae Lee Yonsei University
    Korea

Day 3 – June 27 (Sat)

Luncheon Symposium 6 Redefining Treatment Targets in IBD: From Disease Clearance to Transmural Healing June 27 (Sat), 11:50-12:30 | Room B
Chairperson(s)
Speaker(s)
  • Redefining UC Treatment Goals: Disease Clearance Insights from VERDICT
    Vipul Jairath Western University
    Canada
  • Transmural Healing as a Treatment Target in CD: Vedolizumab Insights from VECTORS
    Jun Lee Chosun University
    Korea

Day 3 – June 27 (Sat)

Luncheon Symposium 7 Improving Bowel Preparation: From Better Results to Greater Convenience June 27 (Sat), 11:50-12:30 | Room C
Chairperson(s)
Speaker(s)
  • Efficacy and Safety of DWJ1609 (CLEANCOL): A New 20-Tablet Oral Sulfate Solution for Bowel Preparation
     Sung Hoon Jung The Catholic University of Korea
    Korea
  • Clinical Benefits of DWJ1609 (CLEANCOL): Enhancing Patient Compliance with Reduced Pill Burden
     Subum Park Pusan National University
    Korea
Hosted by
  • AOCC
  • KASID
Supported by
Korea Tourism Organization Seoul Metropolitan Government
Blue
Diamond
한국애브비
삼성바이오에피스
셀트리온제약
한국존슨앤드존슨
Diamond
한국다케다제약
Gold
한국페링제약
대웅제약
Silver
한국화이자제약
한국에자이
(주)유한양행
GSK